Nothing makes you feel more vulnerable at work than sharing a life-altering health diagnosis, especially as a leader who is ...

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...

Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message ...